GIBSON INDEX NEWSLETTER - SEPTEMBER 2009

The company’s Polymer Coatings Division has developed a novel hydrophilic surface treatment to reduce friction on catheters called GlideMax, which is available for licensing, and is using its polymer coating technology in a number of research collaborations developing novel products for the $5 billion drug-eluting stent market. ................
................

In order to avoid copyright disputes, this page is only a partial summary.

Google Online Preview   Download